{"id":24253,"date":"2019-11-22T15:06:36","date_gmt":"2019-11-22T14:06:36","guid":{"rendered":"https:\/\/staging.capitalmind.com\/deals\/cession-des-laboratoires-dr-rinderknecht-gynlab\/"},"modified":"2021-06-24T19:18:53","modified_gmt":"2021-06-24T17:18:53","slug":"cession-des-laboratoires-dr-rinderknecht-gynlab","status":"publish","type":"deals","link":"https:\/\/dev2.capitalmind.com\/fr\/deals\/cession-des-laboratoires-dr-rinderknecht-gynlab\/","title":{"rendered":"Cession des Laboratoires Dr. Rinderknecht &#038; Gynlab"},"content":{"rendered":"<h2>Contexte de l&rsquo;op\u00e9ration<\/h2>\n<p><span class=\"VIiyi\" lang=\"fr\"><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"fr\" data-language-to-translate-into=\"en\" data-phrase-index=\"0\">Reposant sur ses innovations et une client\u00e8le fid\u00e8le, le Dr Rinderknecht a cr\u00e9e un laboratoire unique de cytologie gyn\u00e9cologique en Suisse.<\/span><\/span><\/p>\n<p>Unilabs est l\u2019un des leaders europ\u00e9ens des services diagnostiques et le seul fournisseur \u00e0 proposer des services en m\u00e9decine de laboratoire, imagerie et pathologie au sein d\u2019un seul et m\u00eame groupe. Fond\u00e9 en 1987 avec l\u2019ouverture de trois laboratoires diagnostiques en Suisse, le groupe Unilabs s\u2019est rapidement d\u00e9velopp\u00e9 en appliquant une strat\u00e9gie d\u2019acquisition de laboratoires partenaires de qualit\u00e9 sur l\u2019ensemble du continent europ\u00e9en.<\/p>\n<p><span class=\"VIiyi\" lang=\"fr\"><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"fr\" data-language-to-translate-into=\"en\" data-phrase-index=\"0\">Cette op\u00e9ration illustre l&rsquo;importance croissante des laboratoires sp\u00e9cialis\u00e9s et confirme la tendance \u00e0 la consolidation sur ce segment de march\u00e9.<\/span><\/span><\/p>\n<h2>Notre r\u00f4le<\/h2>\n<p>Investec a conseill\u00e9 l&rsquo;actionnaire fondateur de Labor Dr. Rinderknecht tout au long du process de cession : pr\u00e9paration de la documentation marketing, recherche et s\u00e9lection des acqu\u00e9reurs dans le cadre d\u2019un process comp\u00e9titif, pilotage des due diligences, n\u00e9gociation de l\u2019offre ferme et de la documentation juridique.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Contexte de l&rsquo;op\u00e9ration Reposant sur ses innovations et une client\u00e8le fid\u00e8le, le Dr Rinderknecht a cr\u00e9e un laboratoire unique de&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[3768],"dealtype":[3706],"clienttype":[],"class_list":["post-24253","deals","type-deals","status-publish","hentry","sector-healthcare-fr","dealtype-cession-fr"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/24253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=24253"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=24253"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=24253"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=24253"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=24253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}